ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

THRX Theseus Pharmaceuticals Inc

4,06
0,00 (0,00%)
01 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Theseus Pharmaceuticals Inc THRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 4,06 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,06 4,06
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.2.202415:00EDGAR2Form 15-12G - Securities registration termination [Section..
16.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202420:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
14.2.202420:22EDGAR2Form POS AM - Post-Effective amendments for registration..
14.2.202416:44EDGAR2Form 8-K - Current report
14.2.202416:35EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14.2.202414:30PRNUSTheseus Pharmaceuticals Announces Closing of Tender Offer
13.2.202418:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202423:21EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
07.2.202423:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30.1.202414:52EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30.1.202414:23EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30.1.202414:00BWConcentra Announces Calculation of Additional Price Per..
10.1.202415:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10.1.202414:51EDGAR2Form SC TO-T - Tender offer statement by Third Party
22.12.202312:52EDGAR2Form SC14D9C - Written communication relating to third party..
22.12.202312:36EDGAR2Form 8-K - Current report
22.12.202312:30PRNUSTheseus Pharmaceuticals Enters into Agreement to Be Acquired..
04.12.202312:30EDGAR2Form 8-K - Current report
27.11.202312:37EDGAR2Form 8-K - Current report
27.11.202312:30PRNUSTheseus Pharmaceuticals Confirms Receipt of Unsolicited..
24.11.202322:23EDGAR2Form SC 13D/A - General statement of acquisition of..
17.11.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15.11.202313:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13.11.202322:05PRNUSTheseus Pharmaceuticals Announces Process to Explore..
07.11.202322:05PRNUSTheseus Pharmaceuticals to Participate in the Stifel 2023..
07.11.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202321:13EDGAR2Form 8-K - Current report
10.8.202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202313:05EDGAR2Form 8-K - Current report
10.8.202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..
19.7.202320:41EDGAR2Form SC 13D/A - General statement of acquisition of..
14.7.202313:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
13.7.202322:08EDGAR2Form 8-K - Current report
13.7.202322:05PRNUSTheseus Pharmaceuticals to Discontinue Enrollment in Phase..
31.5.202313:00PRNUSTheseus Pharmaceuticals to Participate in the Jefferies..
25.5.202323:01PRNUSTheseus Pharmaceuticals Reports Initial Dose Escalation Data..
11.5.202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock